Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services

Publisher： Karger

E-ISSN： 1421-9824|40|5-6|297-310

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.40, Iss.5-6, 2015-0, pp. : 297-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Smoking and Response to Cholinesterase Inhibitor Therapy in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 1, 2004-12 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 1-2, 2003-12 ,pp. : 100-108

Karger

Access to resources Recommend Favorite

Apolipoprotein E Phenotype Alone Does Not Influence Survival in Alzheimer’s Disease: A Population-Based Longitudinal Study

By  

Neuroepidemiology, Vol. 19, Iss. 6, 2000-10 ,pp. : 327-332

Karger

Access to resources Recommend Favorite

Treatment Effects of Therapeutic Cholinesterase Inhibitors on Visuospatial Processing in Alzheimer’s Disease: A Longitudinal Functional MRI Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 29, Iss. 2, 2010-03 ,pp. : 176-188

Karger

Access to resources Recommend Favorite

Economic Analysis of Galantamine, a Cholinesterase Inhibitor, in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease in The Netherlands

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 2, 2002-07 ,pp. : 84-89

Karger

Access to resources Recommend Favorite